pan african digital currency searches

The Huangmaohai Cross-sea Passage was opened to traffic today. At 15: 00 on December 11th, Guangdong-Hong Kong-Macao Greater Bay Area's key traffic project, the Huangmaohai Cross-sea Passage, will be put into trial operation, adding another "key level" to Guangdong-Hong Kong-Macao Greater Bay Area's cross-river traffic network. After opening to traffic, the land transit time from Zhuhai to Jiangmen will be shortened from more than one hour to about 30 minutes.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.TikTok submitted an application to the federal court of Canada to challenge the Canadian government's order to close the company's office. On December 11th, local time, TikTok Canada Branch announced that it had submitted an application to the federal court for review of the government's order to close TikTok's business in Canada. TikTok said that this order will cost hundreds of hard-working local employees their jobs and livelihoods, and they support the community with more than 14 million Canadian users on TikTok every month. TikTok said that it is in the best interest of Canadians to find a meaningful solution and ensure that the local team continues to exist with the TikTok platform. (Interface News)

Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Hong Kong stock Fosun's tourism culture opened 83.25% higher. In the news, the company plans to privatize at a premium of about 95.00%.

The yield of Australian 10-year government bonds continued to rise, rising by 5 basis points to 4.19%.Facewall Intelligence has received a new round of financing of several hundred million yuan. Recently, Facewall Intelligence has completed a new round of financing of several hundred million yuan. This round of financing was jointly led by Loongson Venture Capital, Dinghui Baifu, Zhongguancun Science City Fund and Safran Investment Fund, and Beijing Artificial Intelligence Industry Investment Fund and Zero2IPO followed suit.During the year, the enthusiasm of securities firms for issuing bonds was less than that of the same period last year. Adequate capital is an important condition for securities firms to develop innovative business, enhance market competitiveness and prevent risks. In order to supplement working capital and support business development, this year, brokers have raised more than 1.2 trillion yuan by issuing bonds. The data shows that since the beginning of this year, as of December 10th (according to the starting date of issuance), 67 securities firms have issued a total of 644 bonds, with the total amount of bonds issued reaching 1,224.727 billion yuan. On the whole, compared with the same period of last year, the number of bonds issued by brokers has dropped by 13.56% this year, and the total issuance has dropped by 13.58%. Zhu Keli, executive director of China Information Association, said, "Since the beginning of this year, the' enthusiasm' of securities companies to issue bonds is not as good as last year, which shows that securities companies are more cautious and calm in their attitude towards issuing bonds and actively respond to policy calls such as taking the road of capital-saving and high-quality development. In the future, brokers should further balance the development of light and heavy capital business, reasonably determine the scale and frequency of debt issuance financing, improve the efficiency of capital use and develop more steadily. " (Securities Daily)